Patent details
300663
Product Name:
Turoctocog alfa
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300663
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2167526
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300663
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/13/888
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/11/2013
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
15/04/2014
First Marketing Authorization date:
15/11/2013
Grant date:
22/09/2016
Activation date:
11/07/2028
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
15/04/2014
SPC/SPC Extension Expiration Date:
14/11/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
15/04/2014
Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 BAGSVÆRD, Denmark (DK)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
15/04/2014
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
09/22
Publication date:
02/03/2022
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
2014/17
Publication date:
23/04/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/07/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
22/09/2016
Outgoing Correspondence
Decision grant
1
PDF
/3/6/6/0/0/0400300663/docs/300663_7_outgoingcorrespondence20160926111235530.pdf
22/09/2016
SPC Documents
Certificate SPC
1
PDF
/3/6/6/0/0/0400300663/docs/300663_12_supplprotectioncertificate20160926111011675.pdf
28/10/2014
SPC Documents
Annex SPC
20
PDF
/3/6/6/0/0/0400300663/docs/300663_1_supplprotectioncertificate20201015102957601.pdf
28/10/2014
SPC Documents
Accompanying letter SPC
2
PDF
/3/6/6/0/0/0400300663/docs/300663_2_supplprotectioncertificate20201015102753212.pdf
28/10/2014
SPC Documents
Annex SPC
4
PDF
/3/6/6/0/0/0400300663/docs/300663_3_supplprotectioncertificate20201015102905697.pdf
29/07/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/6/6/0/0/0400300663/docs/300663_8_outgoingcorrespondence20140725.pdf
25/07/2014
SPC Documents
Accompanying letter SPC
1
PDF
/3/6/6/0/0/0400300663/docs/300663_6_supplprotectioncertificate20201015102411324.pdf
13/05/2014
Outgoing Correspondence
Outgoing Letter
3
PDF
/3/6/6/0/0/0400300663/docs/300663_11_outgoingcorrespondence20140513.pdf
17/04/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/6/6/0/0/0400300663/docs/300663_10_outgoingcorrespondence20140417.pdf
15/04/2014
SPC Documents
Marketing Authorization SPC
3
PDF
/3/6/6/0/0/0400300663/docs/300663_0_supplprotectioncertificate20201015101407829.pdf
15/04/2014
SPC Documents
Summary of the characteristics of the product
14
PDF
/3/6/6/0/0/0400300663/docs/300663_4_supplprotectioncertificate20201015101836547.pdf
15/04/2014
SPC Documents
Annex SPC
1
PDF
/3/6/6/0/0/0400300663/docs/300663_5_supplprotectioncertificate20201015101306034.pdf
15/04/2014
Application Form
First filed application form
3
PDF
/3/6/6/0/0/0400300663/docs/300663_9_applicationform20140415.pdf